AMERICAN pharmaceutical product manufacturer PPD has announced plans to expand its laboratory services into Singapore from mid-2009.
15/01/2009
Merck has begun a Phase III study of the therapeutic cancer vaccine Stimuvax (BLP25 liposome vaccine) in Asian patients with advanced non-small cell lung cancer (NSCLC). The study will investigate if Stimuvax can extend overall survival in Asian patients with unresectable stage III NSCLC.
14/12/2009
Australia is falling behind the rest of the world in the take-up of electronic solutions for clinical trials, says Jennie Anderson, CEO of Evado, a clinical software company.
07/12/2009